Magenta Therapeutics Lands $48,500,000 Series A Financing

  • Feed Type
  • Date
    11/17/2016
  • Company Name
    Magenta Therapeutics
  • Mailing Address
    245 First St. 4th Floor Cambridge, MA 02142 USA
  • Company Description
    Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases.
  • Website
    http://www.magentatx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $48,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Atlas Accelerator
  • Venture Investor
    GV
  • Venture Investor
    Access Industries
  • Venture Investor
    Partners Innovation Fund

Trending on Xconomy